132 related articles for article (PubMed ID: 22177599)
21. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors.
Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S
Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447
[TBL] [Abstract][Full Text] [Related]
22. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E
Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
Miyashiro J; Woods KW; Park CH; Liu X; Shi Y; Johnson EF; Bouska JJ; Olson AM; Luo Y; Fry EH; Giranda VL; Penning TD
Bioorg Med Chem Lett; 2009 Aug; 19(15):4050-4. PubMed ID: 19553114
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase.
Tikhe JG; Webber SE; Hostomsky Z; Maegley KA; Ekkers A; Li J; Yu XH; Almassy RJ; Kumpf RA; Boritzki TJ; Zhang C; Calabrese CR; Curtin NJ; Kyle S; Thomas HD; Wang LZ; Calvert AH; Golding BT; Griffin RJ; Newell DR
J Med Chem; 2004 Oct; 47(22):5467-81. PubMed ID: 15481984
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides.
Raffa D; Maggio B; Cascioferro S; Raimondi MV; Schillaci D; Gallo G; Daidone G; Plescia S; Meneghetti F; Bombieri G; Di Cristina A; Pipitone RM; Grimaudo S; Tolomeo M
Eur J Med Chem; 2009 Jan; 44(1):165-78. PubMed ID: 18485541
[TBL] [Abstract][Full Text] [Related]
26. Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases.
McBride CM; Renhowe PA; Heise C; Jansen JM; Lapointe G; Ma S; Piñeda R; Vora J; Wiesmann M; Shafer CM
Bioorg Med Chem Lett; 2006 Jul; 16(13):3595-9. PubMed ID: 16603352
[TBL] [Abstract][Full Text] [Related]
27. Indazole-based ligands for estrogen-related receptor α as potential anti-diabetic agents.
Patch RJ; Huang H; Patel S; Cheung W; Xu G; Zhao BP; Beauchamp DA; Rentzeperis D; Geisler JG; Askari HB; Liu J; Kasturi J; Towers M; Gaul MD; Player MR
Eur J Med Chem; 2017 Sep; 138():830-853. PubMed ID: 28735214
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications.
Chiu J; Xu BY; Chen S; Feng B; Chakrabarti S
Can J Physiol Pharmacol; 2008 Jun; 86(6):365-72. PubMed ID: 18516100
[TBL] [Abstract][Full Text] [Related]
29. Dihydroisoquinolinones: the design and synthesis of a new series of potent inhibitors of poly(ADP-ribose) polymerase.
Suto MJ; Turner WR; Arundel-Suto CM; Werbel LM; Sebolt-Leopold JS
Anticancer Drug Des; 1991 May; 6(2):107-17. PubMed ID: 1903948
[TBL] [Abstract][Full Text] [Related]
30. Design, Synthesis and Biological Evaluation of 6-(2,6-Dichloro-3,5-dimethoxyphenyl)-4-substituted-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors.
Zhang Z; Zhao D; Dai Y; Cheng M; Geng M; Shen J; Ma Y; Ai J; Xiong B
Molecules; 2016 Oct; 21(10):. PubMed ID: 27782099
[TBL] [Abstract][Full Text] [Related]
31. Discovery and SAR of novel, potent and selective hexahydrobenzonaphthyridinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
Torrisi C; Bisbocci M; Ingenito R; Ontoria JM; Rowley M; Schultz-Fademrecht C; Toniatti C; Jones P
Bioorg Med Chem Lett; 2010 Jan; 20(2):448-52. PubMed ID: 20015648
[TBL] [Abstract][Full Text] [Related]
32. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone.
Jagtap PG; Baloglu E; Southan GJ; Mabley JG; Li H; Zhou J; van Duzer J; Salzman AL; Szabó C
J Med Chem; 2005 Aug; 48(16):5100-3. PubMed ID: 16078828
[TBL] [Abstract][Full Text] [Related]
33. Structural Requirements of Some 2-(1-Propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide Derivatives as Poly (ADP-Ribose) Polymerase (PARP) for the Treatment of Cancer: QSAR Approach.
Sharma MC
Interdiscip Sci; 2016 Mar; 8(1):11-22. PubMed ID: 26205198
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of anti-hyperglycemic and lipid lowering agents.
Kumar A; Maurya RA; Sharma S; Ahmad P; Singh AB; Tamrakar AK; Srivastava AK
Bioorg Med Chem; 2009 Jul; 17(14):5285-92. PubMed ID: 19500993
[TBL] [Abstract][Full Text] [Related]
35. Antihyperglycemic activity of 2-methyl-3,4,5-triaryl-1H-pyrroles in SLM and STZ models.
Goel A; Agarwal N; Singh FV; Sharon A; Tiwari P; Dixit M; Pratap R; Srivastava AK; Maulik PR; Ram VJ
Bioorg Med Chem Lett; 2004 Mar; 14(5):1089-92. PubMed ID: 14980641
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
37. Rational approaches to discovery of orally active and brain-penetrable quinazolinone inhibitors of poly(ADP-ribose)polymerase.
Hattori K; Kido Y; Yamamoto H; Ishida J; Kamijo K; Murano K; Ohkubo M; Kinoshita T; Iwashita A; Mihara K; Yamazaki S; Matsuoka N; Teramura Y; Miyake H
J Med Chem; 2004 Aug; 47(17):4151-4. PubMed ID: 15293985
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of KCL-440, a new poly(ADP-ribose) polymerase inhibitor, in the rat middle cerebral artery occlusion model.
Ikeda Y; Hokamura K; Kawai T; Ishiyama J; Ishikawa K; Anraku T; Uno T; Umemura K
Brain Res; 2005 Oct; 1060(1-2):73-80. PubMed ID: 16202986
[TBL] [Abstract][Full Text] [Related]
39. Reversal of neurobehavioral and neurochemical alterations in STZ-induced diabetic rats by FeTMPyP, a peroxynitrite decomposition catalyst and 1,5-Isoquinolinediol a poly(ADP-ribose) polymerase inhibitor.
Jangra A; Datusalia AK; Sharma SS
Neurol Res; 2014 Jul; 36(7):619-26. PubMed ID: 24620961
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of new α aminophosphonate system bearing Indazole moiety and their biological activity.
Ali Na; Zakir S; Patel M; Farooqui M
Eur J Med Chem; 2012 Apr; 50():39-43. PubMed ID: 22341789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
